Cargando…
Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model
Fragile X syndrome (FXS) is the most common monogenetic cause of intellectual disability. The cognitive deficits in the mouse model for this disorder, the Fragile X Mental Retardation 1 (Fmr1) knockout (KO) mouse, have been restored by different pharmacological approaches, among those the blockade o...
Autores principales: | Gomis-González, Maria, Busquets-Garcia, Arnau, Matute, Carlos, Maldonado, Rafael, Mato, Susana, Ozaita, Andrés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042387/ https://www.ncbi.nlm.nih.gov/pubmed/27589806 http://dx.doi.org/10.3390/genes7090056 |
Ejemplares similares
-
Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams–Beuren syndrome
por: Navarro-Romero, Alba, et al.
Publicado: (2022) -
Cannabinoid receptor type-1: breaking the dogmas
por: Busquets Garcia, Arnau, et al.
Publicado: (2016) -
Crystal structures of four indole derivatives as possible cannabinoid allosteric antagonists
por: Kerr, Jamie R., et al.
Publicado: (2015) -
Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists
por: Butler, Helen, et al.
Publicado: (2009) -
Neural Substrates of Incidental Associations and Mediated Learning: The Role of Cannabinoid Receptors
por: Ioannidou, Christina, et al.
Publicado: (2021)